#38, Dr. Mary Rozenman & Dr. Chris Probert, insitro

Dr. Mary Rozenman, Chief Financial Officer and Chief Business Officer at insitro, and Dr. Chris Probert, senior machine learning scientist at insitro discuss how insitro’s discovery process can start on either the clinical or cellular side, why scale is so important in every aspect of insitro’s model, and why diversity of experience and background can be a powerful tool in solving hard problems.